CME - Company ID 0001156375
The table below shows CME GROUP INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $1.88B | $1.54B | $1.69B | $1.64B | $1.58B | $1.53B |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
CME GROUP INC. reported annual revenue of $6.52B for fiscal year 2025. That is up 6.4% from $6.13B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $3.60B (FY 2016) to $6.52B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| - |
| - |
| - |
| Operating income | $1.31B | $972.60M | $1.13B | $1.11B | $1.02B | $1.00B |
| Income tax | $356.60M | $269.00M | $305.20M | $288.60M | $264.10M | $271.30M |
| Net income | - | - | - | - | - | - |
| EPS (diluted) | $3.18 | $2.49 | $2.81 | $2.62 | $2.50 | $2.42 |